164 results on '"Hartmann, Gunther"'
Search Results
2. Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review
3. Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy
4. Poly(I:C) Treatment Prevents Skin Tumor Formation in the Preclinical HPV8 Transgenic Mouse Model
5. Induction and antiviral activity of ferret myxovirus resistance (Mx) protein 1 against influenza A viruses
6. Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus
7. Deficiency in coatomer complex I causes aberrant activation of STING signalling
8. Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial
9. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
10. Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release
11. Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
12. Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy
13. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
14. Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands
15. Malaria parasites both repress host CXCL10 and use it as a cue for growth acceleration
16. Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP kinase inhibition against BRAF-mutated melanoma
17. A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA
18. mRNA N1-2'O-methylation by CMTR1 affects NVL2 mRNA splicing
19. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles
20. Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis
21. Supplementary Figures 8-9 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
22. Data from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
23. Supplementary Figures 2-3 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
24. Supplementary Table 1 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
25. Supplementary Methods, Tables 1-4, Figure Legends 1-9 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
26. Supplementary Figure 4 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
27. Supplementary Figures 4-7 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
28. Supplementary Figure Legend from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
29. Supplementary Figure 1 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
30. Supplementary Figure 5 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
31. Supplementary Figure 3 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
32. Supplementary Figure 1 from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
33. Supplementary Figure 2 from Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
34. Data from Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
35. Quantitative protein biomarker panels: a path to improved clinical practice through proteomics
36. Increased IKKϵ protein stability ensures efficient type I interferon responses in conditions of TBK1 deficiency
37. A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression
38. RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma
39. Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype
40. Innate sensing of mRNA vaccines
41. Poly(I:C) Treatment Prevents Skin Tumor Formation in the Preclinical HPV8 Transgenic Mouse Model
42. NLRP3-Independent Inflammasome Activation By Proteasome Inhibitors
43. Correction: Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing
44. Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner
45. Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
46. RIG-I activation primes and trains innate antiviral immune memory
47. SAMHD1 controls innate immunity by regulating condensation of immunogenic self RNA
48. A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression
49. Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets
50. Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.